It is well established that leukotrienes (LTs), products of the 5-lipoxygenase (5-LO) pathway, participate in inflammatory tissue reactions and immune responses. In the present study, the impact of the 5-LO pathway on vasculogenesis of mouse embryonic stem (ES) cells was investigated.
Introduction
Previous studies have suggested a close connection between inflammatory processes and modulation of stem cell differentiation towards angiogenesis. 1 Regarding embryonic development the first distinct aseptic inflammation takes place when the fertilized ovule starts to implant in the uterus. 2 This process is linked to many hormonal and additional cytokine reactions on the maternal side. 2 Other physiological situations which display connection between inflammation processes and angiogenesis are wound healing, neovascularization after infarction and chronic allergic reactions. 3, 4 The interaction between inflammatory cells, endothelial precursor cells, and endothelial cells plays a crucial role at the local inflammation site. 5, 6 An important group of inflammation mediators are the leukotrienes (LTs). These potent inflammatory agents are derived from arachidonic acid (AA) and are primarily produced by phospholipase A 2 and 5-lipoxygenase (5-LO) in inflammatory cells, e.g. monocytes, macrophages, and granulocytes, or by transcellular metabolism. 7 -9 The initial step of LT synthesis from AA is carried out by 5-LO in conjunction with 5-LO-activating protein (FLAP) to form the epoxide intermediate LTA 4 . 10 Although FLAP does not have enzymatic activity, it transfers AA to 5-LO protein. 11 Downstream in the cascade LTA 4 can be hydrolyzed by LTA 4 hydrolase to LTB 4 , or conjugated with reduced glutathione by LTC 4 synthase to generate LTC 4 . This LT can further be modified by sequential steps to yield LTD 4 and LTE 4 . Collectively, the LTs C 4 , D 4 , and E 4 are known as cysteinyl LTs (CysLTs). 12 They mediate their biological activity via high affinity G-protein-coupled putative seven membrane domain-type cell surface receptors, leading to an increase of intracellular Ca 2+ and reduction of intracellular cAMP levels. 13 In the absence of Ca 2+ , 5-LO only has marginal catalytic activity. 14 The LT family reacts with different LT receptors (LTRs) which differ in their agonist activation capacity and affinity. LTB 4 interacts with the BLT 1 or BLT 2 receptor. The CysLTs interact with at least three different CysLT receptors: CysLT 1 -R, CysLT 2 -R, and GPR 17. 15 Until now the biological functions of 5-LO, LTs, and LTRs in vasculogenesis of ES cells have not been investigated, although there is distinct evidence in the literature showing that LTs can promote angiogenesis under certain conditions. 16 During recent years, it has been shown that embryoid bodies (EBs) derived from pluripotent ES cells of murine and human origin differentiate into endothelial cells 17 as well as different hematopoietic lineages including leucocyte subtypes, e.g. monocytes/macrophages, 18, 19 T-lymphocytes, 20 NK cells, 21 and dendritic cells. 22 In the present study, we show that LTs generated from cells of the myeloid cell lineage regulate vasculogenesis of ES cells, thus corroborating the current opinion that a pro-inflammatory tissue micromilieu favours the differentiation of stem cells towards the endothelial cell lineage.
Methods

ES cell culture and EB formation
The pluripotent murine embryonic stem cell line CCE (StemCell Technologies, NA) was cultured on murine irradiated fibroblast cells in basal Iscove's medium (Biochrom, Berlin, Germany) supplemented with 15% heat-inactivated foetal bovine serum (Sigma-Aldrich, Taufkirchen, Germany), 1% non-essential amino acids, 2 M L-glutamine, 1% sodium pyruvate (all from Biochrom), 0.1 mM 2-mercaptoethanol (Sigma-Aldrich), 100 U/mL penicillin and 100 mg/mL streptomycin (Biochrom) and 1000 U/mL leukaemia inhibitory factor (LIF, Millipore NA) in a humidified environment containing 5% CO 2 at 378C. For differentiation, adherent cells were enzymatically dissociated using 0.25% Trypsin with 1 mM EDTA in HBSS (Gibco, Karlsruhe, Germany) and seeded in 250 mL siliconized spinner flasks (Integra Biosciences, Fernwald, Germany) containing medium as described above, but in the absence of LIF. The spinner flask medium was stirred at 22.5 r.p.m. using a stirrer system (Integra Biosciences, Fernwald, Germany).
Immunohistochemistry, quantitative immunohistochemistry, and confocal laser-scanning microscopy
Immunohistochemistry (IHC) was mainly performed with non-adherent (quantitative IHC) EBs. For 5-LO staining, the respective tissues were fixed for 1 h at 48C in 4% paraformaldehyde in PBS and treated for 10 min with 1% Triton X-100. For other antibody reactions, the tissues were fixed in ice-cold methanol/acetone (7:3) for 1 h at 2208C, and washed with PBS containing 0.01% Triton X-100 (PBST, Sigma-Aldrich).
As primary antibodies, rat anti-mouse PECAM-1 (CD31) (Millipore, Schwalbach, Germany), rat anti-mouse CD45 (Millipore, Schwalbach, Germany), rat anti-mouse CD68 (Morphosys AbD Serotec, Duesseldorf, Germany), and rabbit anti-mouse 5-LO antiserum (Cayman Chemicals, Ann Arbor, USA) were used. Blocking against unspecific binding was performed for 60 min with 10% fat-free milk powder or 5% bovine serum albumin (BSA) (Carl Roth, Karlsruhe, Germany) dissolved in PBST. The tissues were subsequently incubated overnight at 48C with primary antibodies and thereafter washed with PBST and reincubated with either a goat anti-rat Cy5-conjugated IgG (Millipore) or a Cy3-conjugated goat anti-rabbit IgG (Millipore) at a dilution of 1:200 in PBST containing 10% milk powder or 5% BSA. Fluorescence recordings were performed using a confocal laser scanning microscope (LSM 510, Zeiss, Germany) connected to an inverted microscope (Axiovert 135, Zeiss). Fluorescence was determined from the top to a depth of 32 mm of the tissue using sections of 8 mm. Quantitative IHC was analysed as previously described. 23 
Western blot analysis
EBs were washed in phosphate-buffered saline (PBS, pH 7.4) and dissolved in ice-cold standard lysis buffer containing protease inhibitors and 1% phosphatase inhibitor cocktail (Sigma-Aldrich 
Magnetic cell separation and transient calcium signal measurement
CCE EBs were generated and cultivated as described above. EBs were dissociated by incubation for 30 min in serum-free Iscove's medium containing collagenase type II (2 mg/mL, PAA, Coelbe, Germany) at 378C. For the cell separation, an AutoMACS (Miltenyi Biotec, Bergisch-Gladbach, Germany) was used. The separation procedure was carried out using a Biotin-conjugated rat anti-mouse CD105 antibody (dilution 1:10, SouthernBiotech, Birmingham, USA) and a PE-conjugated rat anti-mouse Flk-1 antibody (dilution 1:10, BD, Franklin Lakes, USA) as well as MicroBeadsconjugated to a rat anti-mouse CD11b antibody (dilution 1:10, Miltenyi Biotec, Bergisch-Gladbach, Germany). For labelling anti-biotin and anti-PE MicroBeads (all from Miltenyi Biotec, Bergisch-Gladbach, Germany) were used. Positive selected cells were plated on gelatinecoated glass plates and incubated at 378C and 5% CO 2 for 24 h before analysing them. Cells were loaded with fluo-3/AM and Ca 2+ -signal measurement was performed in E 1 -buffer at a Zeiss cLSM 510 equipped with a 488 nm argon laser. The basal [Ca 2+ ] i concentration was monitored for 10 s. After this time, 250 nM of the relevant LT was added to measure the increase of fluorescence as previously described. 24 
Real-time PCR
Total RNA from CCE EBs was prepared using TRIZOL reagent (Invitrogen, Karlsruhe, Germany) according to manufacturers recommendations followed by genomic DNA digestion using DNase I (Invitrogen, Karlsruhe, Germany). cDNA synthesis was performed using 2 mg RNA and SuperScript RTase II (Invitrogen, Karlsruhe, Germany). Amplifications were performed in a Cycler Optical Module (Applied Biosystems 7500, Foster City, NA) using SYBR w Green (Qiagen, Hilden, Germany). Relative expression values were obtained by normalizing CT values of the tested gene in comparison with CT values of the housekeeping genes using the DD CT method.
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Down regulation of FLAP using shRNA technique
For stable shRNA silencing, pLKO.1-puro (Sigma-Aldrich) derivative plasmids carrying an individual shRNA targeting murine FLAP were separately introduced into CCE cells using HEK293FT-based amphotropic Phoenix packaging cells (Phoenix-Ampho, Invitrogen, Karlsruhe, Germany) and a lentiviral packing mix (Sigma-Aldrich) as previously described. 25 Transduction efficiency was assessed via GFP TM control vector (Sigma-Aldrich). A total of three infection rounds were carried out within 24 h. After transduction, the cells were passaged and selected with 2 mg/mL Puromycin (Sigma-Aldrich) for 10 days. FLAP down regulation was analysed by quantitative IHC and western blot.
Extraction and separation of 20:4 metabolites
For the extraction of LTs, CCE EBs were taken from spinner flask and washed two times with serum free basal Iscoves medium. After that they were incubated for 15 min with 5 mM calcium ionophor A23187 and 50 mM AA (Sigma-Aldrich) for a maximum yield. The 20:4 metabolites were purified and separated by reverse-phase high performance liquid chromatography (HPLC) using a C-18 column (Merck, Darmstadt, Germany) with a mixture of 70:30 (vol/vol) methanol:ammonium acetate. The metabolites were extracted and further purified as previously described. 26, 27 For LTB 4 separation, the solvent (70:30 methanol:ammonium acetate) pH 6.8 was adjusted and the absorbance of column effluents was monitored at 269 nm. Separation of LTD 4 was performed with solvent pH 5.6 and absorbance at 280.
Statistical analyses
Data are presented as weighted mean value + SEM with n denoting the number of experiments unless otherwise indicated. In each experiment, at least 50 -80 EBs were analyzed. t-Test for unpaired data was applied as appropriate. A value of P , 0.05 was considered significant and marked with an asterisk.
Results
5-LO and FLAP are expressed during differentiation of ES cells
To examine whether the 5-LO pathway plays a role during ES cellderived EB differentiation, first the relative mRNA expression level of 5-LO and FLAP was examined using semi-quantitative real-time PCR. These analyses were performed from day 2 to day 16 of EB culture ( Figure 1 ). EBs did not express 5-LO or FLAP before day 5 of culture. In contrast, a significant increase of 5-LO and FLAP mRNA expression was observed in a time frame between day 6 and day 10 of culture. IHC studies showed that 5-LO positive cells appear first in 6-day-old EBs ( Figure 2A) . The relative mRNA level of 5-LO and FLAP decreased after day 10 of cell culture. In contrast, 5-LO positive cells were observed until day 16 of EB differentiation.
Macrophages and leucocytes express 5-LO in EBs
To study the cellular localization of 5-LO within EBs, and to detect cells which potentially produce and secrete LTs, representative IHC double staining against the 5-LO antigen in combination with a specific marker of macrophages (CD68) (Figure 2A and B) and leucocytes (CD45) (Supplementary material online, Figure S1 ) was performed.
It was evident that CD68 + cells first appear at day 8 of EB differentiation. These data were consistent with real-time PCR data of CD68. Figure S1 ). In an early timeframe between day 6 and 8 which included the first appearance of 5-LO, no correlation of 5-LO staining with the examined antigens was found (Figure 2A ).
CCE EBs secrete LTs in a timeframe between day 6 and 10 of differentiation
To correlate leucocyte differentiation with LT synthesis, the relative mRNA expression of LTA 4 hydrolase and LTC 4 synthase was examined ( Figure 3 ). mRNA expression of LTA 4 hydrolase, the enzyme which converts LTA 4 to LTB 4 was hardly expressed until day 5 of EB development. In the following days, the mRNA level increased until day 7. During subsequent cultivation, the expression level declined and remained constant over the time. The LTC 4 synthase mRNA level was upregulated from day 6 of culture and remained highly expressed from day 8 to 11. The released amount of LTs reflects the activity of the corresponding enzyme. Therefore, secretion of LTs was measured using HPLC. Highest secretion of LTB 4 and LTD 4 was observed by HPLC analysis in a timeframe between day 6 and 10 ( Figure 4) . Notably, the amount of released LTB 4 was higher when compared with LTD 4 . At day 12, LT production decreased sharply and remained low until day 16 of EB differentiation. The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells material online, Figure S2 and S3B). These findings were consistent with the mRNA data. The BLT 2 -R was detectable first at day 8 of EB differentiation and subsequently continuously expressed until day 16 of differentiation. CysLT 1 -R and CysLT 2 -R differ in the rank order of agonist activation. Protein analysis as well as mRNA data showed a temporary higher expression of CysLT 1 -R in a timeframe between day 6 and 16 during EB development, whereas it was marginally detectable during early stages of differentiation. In contrast, the CysLT 2 -R, which was hardly detectable during early stages of differentiation, showed a higher protein expression between day 8 and 12 of EB development (Supplementary material online, Figure  S2 and S3A).
Differentiating ES cells express CysLT
A subfraction of CD1051/Flk-11 cells as well as CD11b1 cells express LTRs
When cells derived from 8-day-old EBs were treated with either LTB 4 or LTD 4 , a transient Ca 2+ response was observed in 3-5% of total cells, thus suggesting functionality of the LT signalling pathway in differentiating ES cells ( Figure 5A ). To study whether macrophages and hematopoietic precursor cells (HPC) react on the different type of LTs, cells were purified using magnetic cell separation technique. After this procedure and a 24 h rest, cells were exposed to different LTs and Ca 2+ transients were measured.
Approximately 65% of total single cells from differentiating EBs sorted for Flk-1/CD105, i.e. a marker for HPCs implicated in angiogenesis and heart development, showed Ca 2+ transients in response to LTB 4 ( Figure 5B ). These Flk-1 + /CD105 + cells displayed an elongated endothelial-like phenotype (see false colour images, Figure 5B ). These findings indicated that some Flk-1 + /CD105 + cells carried at least one of the BLT-Rs and that these cells responded towards LTs. In mRNA analyses of Flk-1 positive cells, it was found that these cells express transcripts of 5-LO and FLAP only on a negligible level ( Figure 5C ). Notably, a distinct fraction of single cells sorted positive for CD11b, i.e. a marker for granulocytes and macrophages and displaying a round phenotype with multiple small lamellipodiae showed calcium transients in response to LTD 4 , indicating sensitivity for CysLTs and consecutive expression of either CysLT 1 -R or CysLT 2 -R ( Figure 5D ).
LTB 4 and LTD 4 stimulation of 8-day-old EBs is mediated through phosphorylation of ERK1/2
To investigate which type of MAPK was involved in the 5-LO pathway a functional analysis of the 5-LO signalling pathway after stimulation with either 100 nM LTB 4 or LTD 4 was performed (Supplementary material online, Figure S4 ). Using western blot analysis, the phosphorylation level of ERK1/2, SAPK/JNK, and p38 was investigated. Stimulation with LTB 4 as well as LTD 4 showed an involvement of the ERK1/2 pathway in 8-day-old EBs. A phosphorylation of ERK1/2 was observed in a timeframe between 15 and 60 min after stimulation (Supplementary material online, Figure S4A ). Notably EKR1/2 phosphorylation after stimulation with LTB 4 was not affected by a VEGF-R 2 blockade using SU5614 (Supplementary material online, Figure S4D ). No involvement of p38 phospho and SAPK/JNK phospho could be detected. Therefore, it can be concluded that the SAPK/JNK or the p38 pathway was not involved after stimulation with LTB 4 or LTD 4 when 8-day-old EBs were analysed.
Pharmacological inhibition of FLAP exerts anti-angiogenic effects in differentiating ES cells
According to the working hypothesis of the present study, LT synthesis and signalling play a role in blood vessel differentiation of ES cells. To verify a physiological function of LT secretion on vasculogenesis during EB differentiation, cells were incubated in a timeframe between day 6 and 16 with BAY-u9773 (CysLT-R antagonist with equal affinity to CysLT 1 -R and CysLT 2 -R) and MK591 (FLAP inhibitor) at concentrations between 0.5 and 2 mM (Supplementary material online, Figure S5 and S6). Analyses were carried out using western blot, mRNA analysis, and quantitative IHC. MK591 (Supplementary material online, Figure S6 ) and BAY-u9773 (Supplementary material online, Figure S5 ) both decreased the endothelial cell marker PECAM-1. Using MK591, the PECAM-1 expression as well as PECAM-1-positive cell area measurement was significantly decreased in 10-day-old EBs, thus indicating that pharmacological inhibition of LT signalling significantly inhibited vasculogenesis of ES cells. To exclude toxic effects of the inhibitors, western blot analysis of caspase-3/ cleaved caspase-3 was performed which, however, did not reveal increased apoptosis (data not shown). The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells
Stable shRNA silencing of FLAP in EBs decreases capillary-like areas in EBs during late angiogenesis
To exclude potential pharmacological side effects of the used inhibitors, shRNA targeting of FLAP (Supplementary material online, Figure S7 ) was performed to analyse the effect of gene inactivation of the activator protein on vasculogenesis of ES cells ( Figure 6 ). shRNA targeting of FLAP significantly reduced the cell areas positive for PECAM-1 ( Figure 6A and B) . In addition to that mRNA transcripts of CD34, CD144 and endothelial nitric oxide synthase (eNOS) were significantly down regulated at day 12 after shRNA targeting of FLAP ( Figure 6C) . Interestingly, the strongest effects were observed in late stages of vasculogenesis, i.e. between day 8 and 12 of cell culture. In contrast, only minor effects were observed on day 6 where angioblasts are formed and capillary sprouting is a rare event. Taken together these data clearly demonstrate that vasculogenesis of ES cells is controlled by LT-mediated signalling pathways.
Discussion
Although the relation between inflammation, the cellular immune response, and angiogenesis is well established, 28 the potential involvement of stem cells in these processes and the underlying signalling pathways remain elusive. Since stem cells are a potential source for pro-angiogenic therapies in inflamed, ischaemic tissues, the present study was undertaken to investigate the impact of the proinflammatory 5-LO pathway on vasculogenesis of ES cells. Our data show that differentiating ES cells within EBs express all necessary enzymes of the 5-LO pathway and acquire the ability to synthesize all types of LTs. Although undifferentiated ES cells were devoid of components of the 5-LO pathway, its initialization was observed around day 6 of spontaneous EB differentiation. First, a more nuclear localization was observed which could be an explanation for an initially higher LTB 4 secretion. In later stages, a more cytosolic expression pattern was found. Interestingly, the establishment of LT signalling parallels endothelial differentiation and maturation, early hematopoietic as well as cardiac differentiation processes, 17, 18, 29 thus suggesting mutual interaction of independent differentiation pathways. Around day 6 of EB differentiation, a fraction of cells expressing 5-LO was detectable but was devoid of markers characteristic for specific leucocyte subtypes (e.g. CD68 and CD45). It may be assumed that these early 5-LO + cells belong to a population of cells which direct differentiation processes in autocrine and paracrine manner through secretion of LTs. After day 12 of differentiation, a sudden drop of LT synthesis was observed which may correlate with the spherical growth limitation of EBs.
The time course and physiological significance of LT expression in differentiating ES cells are largely unknown. From studies on adult cells, it is known that 5-LO expression is present in mature macrophages, dendritic cells, foam cells, mast cells, and neutrophilic granulocytes which are located in the asthmatic lung as well as in human atherosclerotic plaques. 30 -32 Our results showed that around day 10 of EB differentiation a subfraction of cells in EBs expresses 5-LO. These cells could be identified as neutrophilic granulocytes, macrophages, or leucocytes. We found an obviously earlier expression and higher expression level of the BLT 1 -R in comparison to BLT 2 -R. These findings indicate that the BLT 1 -R is expressed on a larger population of cells in the EB and that some of the LTB activity is mainly mediated through this receptor. showed a reduction in inflammation intensity and vascular permeability. 35 Our findings indicate that CysLT 2 -R protein expression in the murine EBs is only present in a defined timeframe around day 8-13 of differentiation. Currently, little is known about the function of this receptor. The CysLT 2 -R as well as the BLT 2 -R is expressed on HUVEC cells. 36, 37 Micro-array data suggest after CysLT 2 -R stimulation an upregulation of inflammatory genes. 37 We 23 To investigate whether LTs are involved in the regulation of vasculogenesis, EBs were either incubated with pharmacological inhibitors of LT signalling or FLAP was downregulated by a shRNA approach. Under these conditions, PECAM-1 expression and capillary areas, positive for PECAM-1, were significantly decreased. In parallel CD34, CD144 and eNOS transcripts were significantly downregulated in EBs using shRNA targeting FLAP. This demonstrates that the 5-LO/LT system co-regulates late phases of inflammation mediator triggered ES cell-derived vasculogenesis, although 5LO 2/2 mice showed a normal embryonic development and fertility. 39 Our data suggest that during ongoing differentiation and maturation of hematopoietic progenitor cells, e.g. macrophages, paracrine effects mediated by cytokines or other inflammation mediators may modulate differentiation processes in the ES cells. We hypothesize a model of paracrine interaction of 5-LO positive cells with endothelial cells or endothelial precursor cells in differentiating EBs. This interaction may gain in vivo relevance during embryogenesis or in pathological inflammatory processes where leucocytes including macrophages may blaze the trail for neovascularization or invading endothelial cells through LT signalling. Taking our findings together, the present study provides evidence that all components of LT signalling are expressed in differentiating ES cells, and LT signalling pathways are involved in processes of blood vessel formation. Thus, the ES cell system represents an outstanding model for the study of tissue inflammation, for the assessment of the impact of inflammatory processes for neo-angiogenesis and tissue perfusion as well as for the preclinical testing of newly developed anti-inflammatory drugs.
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